215 related articles for article (PubMed ID: 31408004)
1. Imaging of glucose metabolism by 13C-MRI distinguishes pancreatic cancer subtypes in mice.
Kishimoto S; Brender JR; Crooks DR; Matsumoto S; Seki T; Oshima N; Merkle H; Lin P; Reed G; Chen AP; Ardenkjaer-Larsen JH; Munasinghe J; Saito K; Yamamoto K; Choyke PL; Mitchell J; Lane AN; Fan TW; Linehan WM; Krishna MC
Elife; 2019 Aug; 8():. PubMed ID: 31408004
[TBL] [Abstract][Full Text] [Related]
2. Molecular Imaging of the Tumor Microenvironment Reveals the Relationship between Tumor Oxygenation, Glucose Uptake, and Glycolysis in Pancreatic Ductal Adenocarcinoma.
Yamamoto K; Brender JR; Seki T; Kishimoto S; Oshima N; Choudhuri R; Adler SS; Jagoda EM; Saito K; Devasahayam N; Choyke PL; Mitchell JB; Krishna MC
Cancer Res; 2020 Jun; 80(11):2087-2093. PubMed ID: 32245793
[TBL] [Abstract][Full Text] [Related]
3. Deuterium MRSI characterizations of glucose metabolism in orthotopic pancreatic cancer mouse models.
Markovic S; Roussel T; Agemy L; Sasson K; Preise D; Scherz A; Frydman L
NMR Biomed; 2021 Sep; 34(9):e4569. PubMed ID: 34137085
[TBL] [Abstract][Full Text] [Related]
4. Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival.
Panda A; Garg I; Truty MJ; Kline TL; Johnson MP; Ehman EC; Suman G; Anaam DA; Kemp BJ; Johnson GB; Halfdanarson TR; Venkatesh SK; Fidler JL; Goenka AH
AJR Am J Roentgenol; 2021 Sep; 217(3):730-740. PubMed ID: 33084382
[No Abstract] [Full Text] [Related]
5. MRI evaluation of pancreatic ductal adenocarcinoma: diagnosis, mimics, and staging.
Bowman AW; Bolan CW
Abdom Radiol (NY); 2019 Mar; 44(3):936-949. PubMed ID: 29967986
[TBL] [Abstract][Full Text] [Related]
6. Identification of variable stages in murine pancreatic tumors by a multiparametric approach employing hyperpolarized
Martinho RP; Bao Q; Markovic S; Preise D; Sasson K; Agemy L; Scherz A; Frydman L
NMR Biomed; 2021 Feb; 34(2):e4446. PubMed ID: 33219722
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous characterization of tumor cellularity and the Warburg effect with PET, MRI and hyperpolarized
Hundshammer C; Braeuer M; Müller CA; Hansen AE; Schillmaier M; Düwel S; Feuerecker B; Glaser SJ; Haase A; Weichert W; Steiger K; Cabello J; Schilling F; Hövener JB; Kjær A; Nekolla SG; Schwaiger M
Theranostics; 2018; 8(17):4765-4780. PubMed ID: 30279736
[TBL] [Abstract][Full Text] [Related]
8. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.
Yeh R; Dercle L; Garg I; Wang ZJ; Hough DM; Goenka AH
Abdom Radiol (NY); 2018 Feb; 43(2):415-434. PubMed ID: 29143875
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of three-dimensional fast imaging with steady precession dynamic MR imaging in evaluating pancreatic ductal adenocarcinoma.
Irie H; Honda H; Aibe H; Kuroiwa T; Yoshimitsu K; Shinozaki K; Yamaguchi K; Shimada M; Masuda K
Clin Imaging; 2001; 25(1):50-6. PubMed ID: 11435041
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of response using FDG-PET/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial-PaCa-DD-041 (Eudra-CT 2009-011968-11).
Zimmermann C; Distler M; Jentsch C; Blum S; Folprecht G; Zöphel K; Polster H; Troost EGC; Abolmaali N; Weitz J; Baumann M; Saeger HD; Grützmann R
Strahlenther Onkol; 2021 Jan; 197(1):19-26. PubMed ID: 32638040
[TBL] [Abstract][Full Text] [Related]
11. Accurate Therapeutic Response Assessment of Pancreatic Ductal Adenocarcinoma Using Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging With a Point-of-Care Perfusion Phantom: A Pilot Study.
Kim H; Morgan DE; Schexnailder P; Navari RM; Williams GR; Bart Rose J; Li Y; Paluri R
Invest Radiol; 2019 Jan; 54(1):16-22. PubMed ID: 30138218
[TBL] [Abstract][Full Text] [Related]
12. Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer.
Fendrich V; Schneider R; Maitra A; Jacobsen ID; Opfermann T; Bartsch DK
Neoplasia; 2011 Feb; 13(2):180-6. PubMed ID: 21403843
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic adenocarcinoma: variability in measurements of tumor size among computed tomography, magnetic resonance imaging, and pathologic specimens.
Ma C; Yang P; Li J; Bian Y; Wang L; Lu J
Abdom Radiol (NY); 2020 Mar; 45(3):782-788. PubMed ID: 31292672
[TBL] [Abstract][Full Text] [Related]
14. Prediction of residual tumor and overall survival after first-line surgery in patients with pancreatic ductal adenocarcinoma using preoperative magnetic resonance imaging findings.
Bae JS; Kim JH; Kang HJ; Han JK
Acta Radiol; 2022 Apr; 63(4):435-446. PubMed ID: 33682455
[TBL] [Abstract][Full Text] [Related]
15. Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET/MRI.
Wang ZJ; Behr S; Consunji MV; Yeh BM; Ohliger MA; Gao K; Ko AH; Cinar P; Tempero MA; Collisson EA
AJR Am J Roentgenol; 2018 Nov; 211(5):1010-1019. PubMed ID: 30063366
[TBL] [Abstract][Full Text] [Related]
16. Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer.
Dutta P; Perez MR; Lee J; Kang Y; Pratt M; Salzillo TC; Weygand J; Zacharias NM; Gammon ST; Koay EJ; Kim M; McAllister F; Sen S; Maitra A; Piwnica-Worms D; Fleming JB; Bhattacharya PK
J Proteome Res; 2019 Jul; 18(7):2826-2834. PubMed ID: 31120258
[TBL] [Abstract][Full Text] [Related]
17. PET/CT in brachytherapy early response evaluation of pancreatic ductal adenocarcinoma xenografts: comparison with apparent diffusion coefficient from diffusion-weighted MR imaging.
Liu Y; Liu M; Liu X; Zhou Y
Abdom Radiol (NY); 2019 Mar; 44(3):950-957. PubMed ID: 30315322
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory mimickers of pancreatic adenocarcinoma.
Kothari K; Lopes Vendrami C; Kelahan LC; Shin JS; Mittal P; Miller FH
Abdom Radiol (NY); 2020 May; 45(5):1387-1396. PubMed ID: 31559473
[TBL] [Abstract][Full Text] [Related]
19. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications.
Erkan M; Hausmann S; Michalski CW; Fingerle AA; Dobritz M; Kleeff J; Friess H
Nat Rev Gastroenterol Hepatol; 2012 Aug; 9(8):454-67. PubMed ID: 22710569
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive dynamic monitoring initiation and growth of pancreatic tumor in the LSL-Kras
Hu S; Pan L; Shangguan J; Figini M; Eresen A; Sun C; Wang B; Ma Q; Hu C; Yaghmai V; Velichko Y; Yang J; Zhang Z
J Immunol Methods; 2019 Feb; 465():1-6. PubMed ID: 30468734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
